-
1061
A bibliometric analysis of cardiotoxicity in cancer radiotherapy
Published 2024-04-01“…High-frequency keywords in the analysis include risk factors, cancer types, heart disease, survival, trials, proton therapy (PT), etc.ConclusionFuture research on RIHD will mostly focus on thoracic cancer, whose exact cause is yet unknown, with preclinical trials playing an important role. …”
Get full text
Article -
1062
-
1063
A hybrid multi-particle approach to range assessment-based treatment verification in particle therapy
Published 2023-04-01“…A quasi-monolithic organic detector array is proposed, and its feasibility for detecting range shifts in the context of proton therapy is explored through Monte Carlo simulations of realistic patient models and detector resolution effects. …”
Get full text
Article -
1064
A Portable Three-Layer Compton Camera for Wide-Energy-Range Gamma-ray Imaging: Design, Simulation and Preliminary Testing
Published 2023-11-01“…Further improving the upper energy limit of gamma-ray imaging has important application significance in the active interrogation of special nuclear materials and chemical warfare agents, as well as range verification of proton therapy. (2) Methods: To realize gamma-ray imaging in a wide energy range of 0.3~7 MeV, a principle prototype, named a portable three-layer Compton camera, is developed using the scintillation detector that consists of an silicon photomultiplier array coupled with a Gd<sub>3</sub>Al<sub>2</sub>Ga<sub>3</sub>O<sub>12</sub>:Ce pixelated scintillator array. …”
Get full text
Article -
1065
Geometric and dosimetric impact of 3D generative adversarial network-based metal artifact reduction algorithm on VMAT and IMPT for the head and neck region
Published 2021-06-01“…Abstract Background We investigated the geometric and dosimetric impact of three-dimensional (3D) generative adversarial network (GAN)-based metal artifact reduction (MAR) algorithms on volumetric-modulated arc therapy (VMAT) and intensity-modulated proton therapy (IMPT) for the head and neck region, based on artifact-free computed tomography (CT) volumes with dental fillings. …”
Get full text
Article -
1066
Short and long-term evaluation of the impact of proton minibeam radiation therapy on motor, emotional and cognitive functions
Published 2020-08-01“…Along this line, proton minibeam radiation therapy (pMBRT) is a novel strategy that allows the spatial modulation of the dose, leading to minimal damage to brain structures compared to a high dose (25 Gy in one fraction) of standard proton therapy (PT). The aim of the present study was to evaluate whether pMBRT also preserves important cerebral functions. …”
Get full text
Article -
1067
-
1068
-
1069
-
1070
Global Radiotherapy: Current Status and Future Directions—White Paper
Published 2021-12-01Get full text
Article -
1071
-
1072
-
1073
-
1074
Management of Chordoma and Chondrosarcoma with Fractionated Stereotactic Radiotherapy
Published 2017-06-01“…One patient previously treated with proton therapy died from radiation vasculopathy 9 months after FSRT. …”
Get full text
Article -
1075
An Analysis of Major Target Deviations in Craniospinal Irradiation Treatment Plans for Patients With Intermediate-Risk Medulloblastoma Within a Phase 3 Clinical Trial (Children's O...
Published 2023-01-01“…Conclusions: Although intensity modulated radiation therapy and proton therapy are promising in improving conformity and sparing organs at risk, technology does not substitute for careful anatomic definition of target volumes. …”
Get full text
Article -
1076
High-energy quasi-monoenergetic proton beam from micro-tube targets driven by Laguerre–Gaussian lasers
Published 2023-01-01“…High-energy proton beams with low energy spread and angular divergence are highly valuable in various applications, such as proton therapy, ultrafast science, and nuclear physics. …”
Get full text
Article -
1077
-
1078
An uncertainty metric to evaluate deformation vector fields for dose accumulation in radiotherapy
Published 2018-04-01Get full text
Article -
1079
Improve dosimetric outcome in stage III non-small-cell lung cancer treatment using spot-scanning proton arc (SPArc) therapy
Published 2018-02-01“…Abstract Background To evaluate spot-scanning proton arc therapy (SPArc) and multi-field robust optimized intensity modulated proton therapy (RO-IMPT) in treating stage III non-small-cell lung cancer (NSCLC) patients. …”
Get full text
Article -
1080